Dr. Nina Sanford: A Journey of Dedication and Innovation in Radiation Oncology | Docwire News
Dr. Sanford shares unique experiences and insights on her life and career in this interview with GI Oncology Now.
Related Articles
It’s been an absolutely awful year for Iran and its friends
Iran and its proxies and allies — from Syria to Lebanon to Gaza — have taken a beating in military engagements this year.
Longevity: Healthy diet, exercise, an active social life may be key
What are three steps we can take in 2025 to improve our longevity? Diet, exercise, and social life emerge as three top factors.
Accelerating Action to Halve the Gender Digital Divide by 2030
We’re working to ensure equitable, affordable, and safe access to digital technology for women
A Vegan Celebration of the New Year – San Diego Jewish World
My family and I have a tradition of staying in on New Year’s Eve and I do a Thanksgiving repeat of the Tofurkey surrounded by…
‘Don’t Die’: Netflix Documentary Chronicles the Health Regimen of the Man Who Wants to Live Forever
Tech entrepreneur Bryan Johnson explains his anti-aging regimen as chronicled in the Netflix doc ‘Don’t Die: The Man Who Wants to LIve Forever.’
5 Ways to Improve Longevity in 2025
Want to live a longer life? Try these five simple habits in 2025 that can help increase your life span by years and improve the…
Aaron Siri Sets the Record Straight about Fraudulent NYT Hit Piece Against RFK JR. NO, He Doesn’t Want to Ban Polio Vaccines – The HighWire
Aaron Siri debunks NYT’s false claims, exposing Big Pharma bias and advocating for vaccine safety standards.
US lawmakers eye health insurance reform as frustrations mount
Nearly one in four doctors say the practice of prior authorization has led to serious issues for patients
Burnout and Death: The Story of a CVS Pharmacist
Podcast Episode · Healthcare Unfiltered · 02/27/2024 · 59m
Phase 3 INTerpath-009 Trial of mRNA-4157 Plus Pembrolizumab for NSCLC Begins Recruitment | Docwire News
The pivotal phase 3 INTerpath-009 trial has begun global recruitment of patients with resectable non-small cell lung cancer, according to Merck and Moderna.